DOW:NYSEDow Inc. Analysis
Data as of 2026-09-01 - not real-time
$30.46
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Dow Inc. is neutral at $30.46, with no clear ordering between short and long averages. RSI sits at 48.0, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $29.17 and resistance at $33.40.
On valuation the read is fair — an earnings multiple of 16.6, absent a reliable peer benchmark. Analyst price targets sit 13.9% above the current price. Revenue is growing at 19.7% on a -3.1% profit margin. The 4.59% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 38.1%, a beta of -0.01 and a maximum drawdown of 35.5%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
On valuation the read is fair — an earnings multiple of 16.6, absent a reliable peer benchmark. Analyst price targets sit 13.9% above the current price. Revenue is growing at 19.7% on a -3.1% profit margin. The 4.59% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 38.1%, a beta of -0.01 and a maximum drawdown of 35.5%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
Dow stock is anchored by recent earnings, margin, and cash flow figures while investors track the laDow swung back to profitability on a 30% polyethylene price surge that lifted plastics revenue 27%, with earnings of $1.Benzinga.com1monDow Earnings & ForecastsDow DOW last issued guidance on April 23, 2026 for Q2 2026. The company guided...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 31.36
- MACD momentum is negative
- Maximum drawdown of 35.5%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 4.59% looks stretched against payout coverage
- Trading below the 200-day average of 31.36
- Analyst targets imply +13.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 4.59% looks stretched against payout coverage
- Negative profit margin of -3.1%
- Analyst targets imply +13.9% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth19.70%
Profit Margin-3.13%
P/E Ratio16.6
ROE-5.54%
ROA1.30%
Debt/Equity111.91
P/B Ratio1.4
Op. Cash Flow$3.9B
Free Cash Flow$237.6M
Technical Analysis
TrendNeutral
RSI48.0
Support$29.17
Resistance$33.40
MA 20$30.82
MA 50$29.96
MA 200$31.36
MACDBearish
VolumeIncreasing
Fear & Greed Index92.25
Valuation
Target Price$34.69
Upside/Downside13.88%
GradeFair
TypeBlend
Dividend Yield4.59%
Risk Assessment
Beta-0.01
Volatility38.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.